Author: Abbas, Aymn Talat; El-Kafrawy, Sherif Aly; Sohrab, Sayed Sartaj; Azhar, Esam Ibraheem Ahmed
Title: IgY antibodies for the immunoprophylaxis and therapy of respiratory infections Cord-id: xsfg7uth Document date: 2018_9_19
ID: xsfg7uth
Snippet: Emergence of drug resistance among the causative organisms for respiratory tract infections represents a critical challenge to the global health care community. Further, although vaccination can prevent disease, vaccine development is impeded by several factors. Therefore, novel approaches to treat and manage respiratory infections are urgently needed. Passive immunization represents a possible alternative to meet this need. Immunoglobulin Y antibodies (IgYs) from the yolk of chicken eggs have p
Document: Emergence of drug resistance among the causative organisms for respiratory tract infections represents a critical challenge to the global health care community. Further, although vaccination can prevent disease, vaccine development is impeded by several factors. Therefore, novel approaches to treat and manage respiratory infections are urgently needed. Passive immunization represents a possible alternative to meet this need. Immunoglobulin Y antibodies (IgYs) from the yolk of chicken eggs have previously been used against bacterial and viral infections in human and animals. Their advantages include lack of reaction with mammalian Fc receptors, low production cost, and ease of extraction. Compared to mammalian IgGs, they have higher target specificity and greater binding avidity. They also possess remarkable pathogen-neutralizing activity in the respiratory tract and lungs. In this review, we provide an overview of avian IgYs and describe their potential therapeutic applications for the prevention and treatment of respiratory infections.
Search related documents:
Co phrase search for related documents- abdulaziz city and acute respiratory syndrome: 1, 2, 3, 4, 5
- accepted practice and activity retain: 1
- accepted practice and acute respiratory syndrome: 1, 2, 3, 4
- acid stability and active tuberculosis: 1
- acid stability and activity compromise: 1
- acid stability and activity lose: 1
- acid stability and activity loss: 1
- acid stability and activity retain: 1
- acid stability and activity significant loss: 1
- acid stability and acute respiratory syndrome: 1, 2, 3, 4, 5
- action local rapid onset and additional advantage: 1
- active infection and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active infection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active infection and acute viral infection: 1, 2, 3, 4, 5
- active infection and additional advantage: 1
- active infection patient and acute respiratory infection: 1
- active infection patient and acute respiratory syndrome: 1, 2, 3, 4, 5
- active tuberculosis and acute respiratory infection: 1
- active tuberculosis and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8
Co phrase search for related documents, hyperlinks ordered by date